Reviva Pharmaceuticals Holdings Inc. Warrants (RVPHW)
$0.00
$0.00
(-16.67%)
As on 12-Dec-2025 15:53EDT
Market cap
--
Revenue (TTM)
--
P/E Ratio
--
P/B Ratio
--
Div. Yield
--
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
--
-
ROE
--
-
ROCE
--
-
Industry P/E
--
-
EV/EBITDA
--
-
Debt to Equity
--
-
Book Value
--
-
EPS
--
-
Face value
--
-
Shares outstanding
--
5 Years Aggregate
CFO
$-61.90 Mln
EBITDA
$-35.33 Mln
Net Profit
$-76.75 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Reviva Pharmaceuticals Holdings Inc. Warrants (RVPHW)
| -98.2 | -90.1 | -95.4 | -99.2 | -85.1 | -66.7 | -- |
|
BSE Sensex*
| -11.7 | -4.8 | 1.1 | -8.2 | 3.9 | 5.1 | 10.0 |
|
Company
|
2024
|
2023
|
|---|---|---|
|
Reviva Pharmaceuticals Holdings Inc. Warrants (RVPHW)
| -88.3 | 44.4 |
|
BSE Sensex
| 8.1 | 18.7 |
|
BSE Sensex
| 8.1 | 18.7 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout Reviva Pharmaceuticals Holdings Inc. Warrants (RVPHW)
Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and... cardiometabolic diseases. The company's lead product candidate comprises brilaroxazine (RP5063) for the treatment of neuropsychiatric indications, including schizophrenia, bipolar disorder, major depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia and Alzheimer's disease, and Parkinson's disease psychosis; in clinical development for respiratory indications, such as pulmonary arterial hypertension and idiopathic pulmonary fibrosis; and in preclinical development for the treatment of psoriasis. It is also developing RP1208 for the treatment of depression and obesity. The company was founded in 2018 and is headquartered in Cupertino, California. Read more
-
Founder, CEO, President & Director
Dr. Laxminarayan Bhat Ph.D.
-
Founder, CEO, President & Director
Dr. Laxminarayan Bhat Ph.D.
-
Headquarters
Cupertino, CA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Reviva Pharmaceuticals Holdings Inc. Warrants (RVPHW)
What is the current share price of Reviva Pharmaceuticals Holdings Inc Warrants (RVPHW) Today?
The share price of Reviva Pharmaceuticals Holdings Inc Warrants (RVPHW) is $0.00 (NASDAQ) as of 12-Dec-2025 15:53 EDT. Reviva Pharmaceuticals Holdings Inc Warrants (RVPHW) has given a return of -85.06% in the last 3 years.
What is the current PB & PE ratio of Reviva Pharmaceuticals Holdings Inc Warrants (RVPHW)?
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2024 |
-0.26 |
9.42 |
2023 |
-1.02 |
6.98 |
2022 |
-0.83 |
2.41 |
2021 |
-0.59 |
0.18 |
2020 |
-1.65 |
1.14 |
What is the 52 Week High and Low of Reviva Pharmaceuticals Holdings Inc Warrants (RVPHW)?
The 52-week high and low of Reviva Pharmaceuticals Holdings Inc Warrants (RVPHW) are Rs 0.46 and Rs 0.00 as of 12-Sep-2026.
What is the market cap of Reviva Pharmaceuticals Holdings Inc Warrants (RVPHW)?
Reviva Pharmaceuticals Holdings Inc Warrants (RVPHW) has a market capitalisation of $ 86 Mln as on 12-Dec-2025. As per SEBI classification, it is a company.
Should I invest in Reviva Pharmaceuticals Holdings Inc Warrants (RVPHW)?
Before investing in Reviva Pharmaceuticals Holdings Inc Warrants (RVPHW), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.